For example, oncogenic mutants of RTK, Ras, or Raf can paradoxically induce growth inhibition in normal cells as well as in certain tumor cells, suggesting that this oncogene-induced growth inhibitory signaling may be an obstacle in the path of carcinogenesis [26,27,28]. This evidence concerns the gene RAF1 and neoplasm.